Lack of fragile X mental retardation protein (FMRP) causes Fragile X Syndrome, the most common form of inherited mental retardation. FMRP is an RNA-binding protein and is a component of messenger ribonucleoprotein complexes, associated with brain polyribosomes, including dendritic polysomes. FMRP is therefore thought to be involved in translational control of specific mRNAs at synaptic sites. In mice lacking FMRP, protein synthesisdependent synaptic plasticity is altered and structural malformations of dendritic protrusions occur. One hypothesized cause of the disease mechanism is based on exaggerated group I mGluR receptor activation. In this study, we examined the effect of the mGluR5 antagonist MPEP on Fragile X related behavior in Fmr1 KO mice. Our results demonstrate a clear defect in prepulse inhibition of startle in Fmr1 KO mice, that could be rescued by MPEP. Moreover, we show for the first time a structural rescue of Fragile X related protrusion morphology with two independent mGluR5 antagonists.
Introduction
Fragile X syndrome (FXS) is the most common heritable form of mental retardation. The syndrome is caused by a lack of expression of FMRP (fragile X mental retardation protein), which is the protein product of the FMR1 gene. In most cases, the lack of expression is caused by expansion of a CGG repeat (N200 U) in the 5ô UTR of the FMR1 gene, leading to methylation of both the CGG repeat and the promoter region, accompanied by transcriptional silencing. FMRP is an RNA-binding protein that associates with polyribosomes and is localized in neurons in the form of granules that move in a microtubule dependent manner with the speed of RNA transport (Antar et al., 2005; De Diego Otero et al., 2002; Wang et al., 2008) . Moreover, FMRP has been shown to influence the translation efficacy of several of its target mRNAs (reviewed in Bagni and Greenough, 2005; Bardoni et al., 2006; Zalfa et al., 2007) , which also implicates local translation at synaptic sites (Greenough et al., 2001; Muddashetty et al., 2007; Weiler et al., 1997 Weiler et al., , 2004 . In most cases, FMRP acts as a translational repressor (Laggerbauer et al., 2001; Lu et al., 2004) . Therefore, FMRP is thought to be involved in the transport and/or the regulation of local mRNA translation at synaptic sites (Bagni and Greenough, 2005; Miyashiro et al., 2003; Weiler et al., 1997 Weiler et al., , 2004 . The presumed loss of translational regulation at synaptic sites might underlie the cognitive impairment in FXS (Huber et al., 2000) .
Over the last few years, the metabotropic glutamate receptor (mGluR) theory of FXS has gained much support (Bear et al., 2004) . The mGluR theory states that AMPA receptor internalization triggered by mGluR5 stimulation (Snyder et al., 2001) , is exaggerated in Fmr1 KO mice, accounting for the enhanced hippocampal LTD found in knockout mice (Bear et al., 2004; Huber et al., 2002) . Recently it was shown that FMRP deficient dendrites indeed show aberrant AMPA receptor trafficking resulting in a significantly reduced number of AMPA receptors at the plasma membrane (Nakamoto et al., 2007) . Moreover, Fmr1 KO mice that are crossbred with mice that have a 50% reduction in mGluR5 expression were shown to be rescued in several phenotypic aspects (Dolen et al., 2007) . It is hypothesized that FMRP normally is involved in the inhibition of the translation of several local mRNAs that are important for the mediation of AMPA receptor internalization. Since the amount of AMPA receptors in the postsynaptic density is correlated with protrusion shape, this might also explain the immature protrusion morphology that has been found in different brain areas of both fragile X patients and Fmr1 KO mice (Comery et al., 1997; Galvez and Greenough, 2005; Grossman et al., 2006; Hinton et al., 1991; Koekkoek et al., 2005; Nimchinsky et al., Neurobiology of Disease 31 (2008) 127-132 
